Company Valuation: Sanofi

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 112,310 98,877 111,194 112,665 112,549 131,018 - -
Change - -11.96% 12.46% 1.32% -0.1% 16.41% - -
Enterprise Value (EV) 1 128,816 107,666 121,177 119,102 120,342 138,879 135,209 130,833
Change - -16.42% 12.55% -1.71% 1.04% 15.4% -2.64% -3.24%
P/E ratio 40x 8.01x 17.8x 16.7x 20.8x 19.9x 15.6x 13.9x
PBR 1.9x 1.57x 1.62x 1.5x 1.52x 1.71x 1.63x 1.55x
PEG - 0x -0.4x 2.07x -1.1x 0.9x 0.6x 1.1x
Capitalization / Revenue 3.11x 2.74x 2.94x 2.62x 2.61x 2.77x 2.59x 2.45x
EV / Revenue 3.57x 2.99x 3.21x 2.77x 2.79x 2.94x 2.67x 2.44x
EV / EBITDA 10.8x 9.41x 9.95x 8.14x 8.44x 10.2x 8.74x 7.94x
EV / EBIT 13.2x 11x 11.3x 9.13x 9.5x 11.1x 9.51x 8.47x
EV / FCF 21.7x 15.4x 15x 14x 14.2x 19.4x 14.4x 12.7x
FCF Yield 4.6% 6.48% 6.68% 7.12% 7.04% 5.16% 6.94% 7.89%
Dividend per Share 2 3.15 3.2 3.33 3.56 3.76 3.842 4.064 4.472
Rate of return 3.51% 4.07% 3.76% 3.96% 4.19% 3.67% 3.89% 4.28%
EPS 2 2.24 9.82 4.97 5.37 4.31 5.261 6.701 7.541
Distribution rate 141% 32.6% 67% 66.3% 87.2% 73% 60.6% 59.3%
Net sales 1 36,126 36,041 37,761 42,997 43,070 47,263 50,606 53,582
EBITDA 1 11,904 11,443 12,183 14,627 14,259 13,666 15,462 16,474
EBIT 1 9,758 9,762 10,714 13,040 12,670 12,511 14,225 15,444
Net income 1 2,806 12,314 6,223 6,720 5,400 6,658 8,933 9,986
Net Debt 1 16,506 8,789 9,983 6,437 7,793 7,861 4,192 -184.2
Reference price 2 89.62 78.70 88.58 89.84 89.76 104.54 104.54 104.54
Nbr of stocks (in thousands) 1,253,178 1,256,375 1,255,293 1,254,060 1,253,891 1,253,277 - -
Announcement Date 06/02/20 05/02/21 04/02/22 03/02/23 01/02/24 - - -
1EUR in Million2EUR
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
19.88x2.94x10.17x+3.67%145B
58.18x18.04x43.81x+0.58%813B
38.81x13.49x27.47x+1.29%582B
21.05x4.55x12.91x+2.85%396B
37.64x7.13x15.41x+3.22%342B
15.71x4.99x11.43x+2.61%299B
16.36x3.88x10.15x+3.59%262B
29.75x5.34x15.82x+1.85%258B
21.17x5.01x12.68x+3.22%237B
48.68x6.7x11.8x+2.86%172B
Average 30.72x 7.21x 17.17x +2.57% 350.56B
Weighted average by Cap. 35.37x 9.53x 22.43x +2.12%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW